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Abstract
Based on an extensive review of the needle exchange program (NEP) literature, the author sought
to identify weaknesses in NEP evaluations published to date. Surprisingly, it was apparent that NEP
researchers often fail to: (1) collect comparison/change data; (2) agree on appropriate and
consistent dependent variables to measure; (3) use valid and reliable measurement instruments; (4)
present clear operational definitions; (5) analyze outcome measures by gender/race/social context;
(6) provide data on type of drug injected as it relates to risky drug and sexual behaviors; (7)
measure HIV/AIDS knowledge; or, (8) clearly articulate desired NEP outcomes. Suggestions for
future research are included, and conclusions about the overall state of NEP evaluative research
are drawn.
Background
The moral, ethical, and legal debate continues over estab-
lishing and maintaining needle exchange programs
(NEPs) in the U.S. and abroad. NEP opponents repeatedly
call for "proof" of NEP effectiveness, fearing NEP use leads
to increased drug use, more crime and more discarded
needles, a health concern for the general public at large.
There have been thousands of published NEP articles,
ranging from popular press accounts of legal battles over
NEPs to longitudinal and/or cross-sectional studies con-
ducted over several years with thousands of injection drug
users (IDUs).
Given many programs, in many different places, operat-
ing with different methods of evaluation, it has been dif-
ficult to compare and evaluate the overall success of NEPs
[1]. Lacking the definitive, random-assignment clinical
trial that is impossible for political, logistical, and ethical
reasons, substantiating positive effects has been difficult
[2]. To achieve that, and answer the general research ques-
tion about the societal impact of NEPs on risky drug and
sexual behaviors, both summative interpretive analyses
and objective, quantitative meta-analyses of NEP evalua-
tive studies have been undertaken.
At least eight interpretive analyses have been published
summarizing the results of studies focused on NEP effec-
tiveness [3-10]. In general, these narrative overviews con-
clude that NEPs are a useful tool to control the spread of
HIV/AIDS.
More recently, a smaller group of researchers, enumerated
below, have begun to examine data related to NEP effec-
tiveness via meta-analysis, a statistical technique for quan-
titative, objective analysis of the results across studies,
rather than an interpretive one. Des Jarlais et al. [11] used
meta-analytic techniques to combine the results of three
studies related to NEP effectiveness, and their results indi-
cated that participation in NEPs was associated with a
lower rate of HIV infection. Cross, Saunders, and Bartelli
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[12] examined U.S. and international data from ten NEP
effectiveness studies conducted between 1984 and 1995,
and concluded that NEPs were associated with reductions
in needle sharing. Ksobiech [13] conducted a meta-analy-
sis of 47 studies focusing on needle sharing, lending, and
borrowing behaviors of NEP attenders, taken from data
gathered between 1984 and 1997, and also found an
inverse relationship between NEP attendance and risky
needle-related behaviors.
To quantitatively extend NEP outcome measurements
beyond needle sharing, Ksobiech [14] conducted a meta-
analysis of NEP effectiveness studies in both the United
States and abroad. A total of 64 studies, measuring 83 dif-
ferent dependent variables related to risky drug and sex
behaviors as well as HIV/AIDS knowledge, were involved.
Because of the multitude of variables, eleven separate
meta-analyses were run on conceptually similar variables.
Sample size for any given meta-analysis ranged from a low
of 2,880 for HIV/AIDS knowledge to a high of 50,423 for
injection frequency. The study found desirable societal
outcomes associated with NEP attendance longitudinally,
cross-sectionally, and by frequency of NEP attendance.
While the general conclusion of all these summary-type
projects is favorable with respect to NEP effectiveness,
they have also noted problems in areas such as generaliz-
ability, control, validity, and reliability. To address these
concerns, the writer of this paper sought to review, in gen-
eral terms, the NEP literature and determine whether
these concerns are significant overall, or simply some-
one's reservations regarding a few selected NEP studies.
In order to complete a series of investigations not pre-
sented or discussed herein, all available NEP evaluative
studies conducted from January 1988 to July 2001 were
gathered and reviewed. To that end, a variety of databases
in which NEP evaluative studies might appear were
searched for relevant citations. They were: AIDSLINE;
MEDLINE; PSYCINFO; ABC POL SCI/GOVT; ALT-
HEALTH WATCH; CINAHL; HEALTH SOURCE PLUS;
SOCIAL SCIENCES INDEX; SOCIOLOGICAL
ABSTRACTS; WEB OF SCIENCE; CONFERENCE PAPERS
INDEX; and DISSERTATION ABSTRACTS ONLINE. The
intent was to locate all NEP studies conducted in the
United States and throughout the world. Cumulatively,
the databases yielded more than 5,000 references, with
considerable replication. In addition, on-line resources
such as Project SERO and the Centers for Disease Con-
trol's web site were thoroughly examined to determine if
any studies had been overlooked; this step added approx-
imately 50 citations to the emerging bibliography.
To begin the process of reviewing the bibliography, cita-
tions that were clearly unrelated to the purpose described
here were eliminated (e.g., the publication was not an aca-
demic source, such as AIDS Weekly Plus, or abstract infor-
mation indicated that the published work was an
editorial, letter, or less than one page in length). Many
such articles were available on-line, and could be quickly
examined before being eliminated. That initial review, as
well as the elimination of duplicate citations, narrowed
the number of bibliographic entries to approximately
3,000. Via reading abstracts and summaries, that number
was again reduced to approximately 500 articles, which
served as the basis for the observations and conclusions
drawn in this article.
The 500 articles were then examined to identify the posi-
tive and negative aspects of the NEP evaluative literature
taken as a whole. While there were indeed many desirable
NEP outcomes, primarily focused on the impact that
NEPs have in controlling the spread of HIV/AIDS via
reductions in needle sharing, those results are not summa-
rized herein. Rather, the remainder of this paper focuses
on enumerating problems, primarily methodological,
which are relatively common in NEP evaluative studies,
presenting a number of suggestions for future research, as
well as offering some overall conclusions regarding NEP
research.
Problem areas in analyzing NEP evaluative 
research
Lack of comparison/change data
Perhaps the most striking problem in the NEP evaluative
literature was that many of the studies were primarily
descriptive. In study after study, information regarding
hours of NEP operation, number/type of locations,
number of IDUs served, number of needles distributed
and returned, IDU employment status, age, gender, and
educational background was summarized, as if this were
an annual report to stakeholders. While that information
can be useful, there was often no data whatever regarding
NEP effectiveness in reducing risky drug and sexual behav-
iors, or increasing HIV/AIDS knowledge. Indeed, there
was often no comparative data whatever; even the limited
descriptive information presented was often not com-
pared to the prior year.
Clearly, researchers must gather comparison and/or
change data regarding a given NEP. How do NEP attend-
ers differ from non-attenders? How have the risky drug
and sexual behaviors of NEP attenders changed over time,
if at all? Is frequency of NEP attendance associated with
desirable behavioral outcomes, such as a reduction in nee-
dle sharing?
NEP research is well past the merely descriptive types of
studies represented in the bulk of the examined publica-
tions. The point has been quite well made that many nee-Harm Reduction Journal 2004, 1 http://www.harmreductionjournal.com/content/1/1/4
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dles are distributed and returned, that many IDUs are
served, and that condoms and informational brochures
are sometimes distributed to IDUs. Surprisingly, at least to
this researcher, was the fact that only 64 NEP evaluative
studies contained change and/or comparison evaluative
data of any kind on the relative effectiveness of these pro-
grams (a full listing of these studies is available upon
request of the author). Reporting on IDU needle sharing
behavior at a fixed point in time does little to advance the
body of knowledge regarding NEP effectiveness, and per-
mits others, whose intentions are not always friendly with
respect to NEPs, to interpret the limited available evidence
in a fashion supportive of their particular viewpoint.
Lack of agreement on appropriate and consistent 
dependent variables across studies
There is great disparity across NEP evaluative studies
regarding what information should be gathered from
IDUs. This disparity in dependent variables occurs in var-
ious ways, and limits comparisons across studies. For
example, some researchers gather data on injection fre-
quency per month [15], while others ask about injection
frequency per day [16], thus making comparisons across
studies difficult at best. Some report and analyze raw data
while others collapse presumably ratio or interval data
into ordinal categories for subsequent analysis. While it is
not wrong per se, the net result is studies with clearly dif-
ferent, non-comparable outcome measures.
Even when the same dependent variables are assessed, it is
not uncommon to find those assessments made at differ-
ent times, especially in follow-up evaluations (30 days vs.
90 days vs. 120 days, etc.). Can't there be agreement as to
what is the appropriate length of time between baseline
and follow-up measurements across studies?
Further, distinctions between types of sharing partners
were made by some researchers, but not by most. Does it
really matter if one lends a needle to a running partner as
opposed to a sexual partner or friend [17]? If so, shouldn't
this line of questioning be incorporated into more, if not
all, NEP research? Frankly, one may legitimately question
whether IDUs can accurately recognize, remember, and
report such subtle distinctions as those described.
Lack of data on reliability and validity of measurement 
instruments
At present, there does not appear to be a frequently uti-
lized series of standard questions and/or measurement
instruments employed to consistently assess various NEP-
related outcomes across studies. Instead, one typically
finds little more than a description of the questionnaire
and/or measurement instrument with little, if any, sup-
porting data regarding validity or reliability. Did the scales
actually measure the concept in question? Did the test
actually assess the HIV/AIDS knowledge level of the
IDUs? Readers are left to draw their own conclusions time
and time again. Thus, with unanswered questions in the
areas of reliability and validity as well as researchers utiliz-
ing different questionnaires and measurement instru-
ments across multiple studies, it is not surprising to find
there are wide-ranging results on any given concept. Com-
paring results across studies, synthesizing results, and con-
structing theories to predict, explain and control the
manner in which NEPs ought to be utilized becomes
problematic.
Lack of clear operational definitions
Perhaps the wide-ranging results reported in NEP evalua-
tions are related to unclear operational definitions of
dependent variables. For example, what exactly is meant
by the term "needle sharing," as used within and across
NEP evaluations? Does it mean the NEP client participat-
ing in the study injected a drug with a needle that had
been used by another person who is present? Must the
person be present? Must they have already used the nee-
dle? If so, hasn't the client (or IDU) actually "borrowed"
the needle from that person and thus the behavior could
be labeled as "needle borrowing" as opposed to "needle
sharing"? If an IDU who is an NEP client "lends" a needle
to another person, is that conceptually the same as "shar-
ing," or must that needle already have been used by the
IDU prior to its "going over" to another person in order to
qualify as lending? How exactly do we meaningfully dif-
ferentiate among sharing, borrowing and lending in a
consistent fashion across NEP studies? The answer, of
course, is via the same operational definition, and yet the
literature reviewed herein demonstrates that those distinc-
tions have not yet been made within and/or across multi-
ple NEP evaluations.
Need for a category system/typology
The 64 change/comparison studies identified in this liter-
ature search provided data on 83 separate dependent var-
iables. Ksobiech [14] has suggested a typology which
placed these dependent variables into a series of catego-
ries developed to conceptually and theoretically organize
the variables: needle sharing, needle sharing-extended
(includes variations on the basic needle sharing ques-
tion); lending/borrowing behaviors; risky circumstances/
context; injection frequency; HIV rate; drug parapherna-
lia-sharing; drug preparation behaviors; syringe use; sex-
ual risk behaviors; and disease/HIV knowledge. Table 1
(see Additional File 1) presents each category and a com-
plete listing of the variables placed within it, and illus-
trates the plethora of different variables assessed by
different NEP researchers. Additional work in this area is
needed. Agreement across researchers on the category
scheme to be used, and the variables contained within
each category, would do much to standardize the infor-Harm Reduction Journal 2004, 1 http://www.harmreductionjournal.com/content/1/1/4
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mation gathered and enhance comparability across stud-
ies.
Lack of data analysis by gender/race/social context
While NEP evaluations present basic demographic, they
typically go no further, failing to examine risky drug and
or sexual behaviors, while controlling for gender, race, or
social context, even though prior research those could be
moderator variables. Campbell [18] reported that female
IDUs are more likely to be dependent upon male sexual
partners for drugs and equipment, and prefer injecting
with sexual partners. Further, women have an economic
disadvantage in these relationships; male sexual partners
are also often women's drug suppliers. Because of their
lower status in the drug-using hierarchy, women are also
more likely to be the last person to inject a drug, conse-
quently using equipment and paraphernalia already "dirt-
ied" by others [18].
Social contexts, and the interpersonal relationships found
within them, may also be predictors of drug and sexual
risk behaviors. For example, males frequently use shoot-
ing galleries, leading to sharing drug paraphernalia, re-
using injection equipment, and/or injecting more fre-
quently than they would in less risky environments [19].
Miller, Eskild, Mella, Moi and Magnus [20] found that
women reported a higher rate of injection frequency,
although not a greater use of NEPs.
Siegal et al. [21] found that there were both geographic
and ethnic differences on choices of drug used. Most NEP
studies examined did not report on drugs used by race/
ethnicity. Therefore, it would be a valuable addition to
NEP articles for the outcome data to be summarized, if
not statistically analyzed, by gender, as well as by race/eth-
nicity (particularly in the U.S.), in order to further refine
the results, and allow for comparisons across studies with
similar refinements.
Lack of information on types of drugs used and risky drug 
behaviors
Injecting different drugs leads to different effects, and is
related to the frequency of injection necessary to maintain
that effect. When Bruneau, Lamothe, et al. [22] found
unexpectedly riskier drug behaviors among NEP clients as
compared with non-attenders, they searched for an expla-
nation. One plausible explanation could be related to the
availability of particular drugs during the times IDUs are
being assessed. In a follow-up commentary, Bruneau,
Franco, and Lamothe [23] state that "cocaine bingeing in
the context of shooting galleries can create situations of
suboptimal utilization of sterile injection equipment" (p.
1009), possibly also impacting HIV incidence.
If type of drugs used is, in fact, a confounding variable,
why haven't NEP researchers routinely asked and reported
on type of drugs injected, and their relationship to other
risky drug behaviors, such as injection frequency? In a
non-NEP study, Singer, Himmelgreen, Dushay and Weeks
[24] found that geographic location, ethnicity and type of
drug injected combine as a predictor of injection fre-
quency. Watters, Estilo, Clark and Lorvick [25] found that
cocaine injection was a predictor of syringe sharing. Gath-
ering more of this type of information for NEP attenders
specifically may lead to the creation of a variety of inter-
vention programs for IDUs who inject themselves with
particular types of drugs.
Lack of information and/or activity regarding risky sexual 
behaviors
While NEP advocates often include reducing risky sexual
behaviors and increasing HIV risk knowledge as NEP
goals, the bulk of the evidence gathered to date has been
in the area of risky drug behaviors. Only 13 studies meas-
ured a change/comparison in behavioral outcomes
related to condom use, sex partners, or sex work (see, for
example, Archibald et al. [26]; Hart et al. [27]; and Latta
[28]).
Risky sexual behaviors of IDUs are becoming an increas-
ing source of the spread of HIV/AIDS beyond the IDU
population [29]. Thus, providing clean needles is not
enough to stem the tide of the epidemic in this dual trans-
mission risk population. Rather, a more all-encompassing
approach, including an emphasis on diminishing risky
sexual behaviors, needs to be implemented, and its out-
comes measured. Always using clean needles, while
simultaneously engaging in unprotected sex, places IDUs,
and the wider population associated with those IDUs, at
disproportionate risk for acquiring and spreading HIV/
AIDS.
Lack of information on HIV/AIDS knowledge among IDUs
Most of the risk behavior models and/or theories suggest
(see, for example, AIDS Risk Reduction Model [30]; or
Theory of Reasoned Action [31]) that HIV/AIDS knowl-
edge must be present and related risky behaviors
"labeled" as such before an IDU will consider changing
his/her behavioral intent, and, ultimately, his/her behav-
ior. To omit or minimize the study of HIV risk knowledge
with NEP attenders, whether intentionally or not, is to
reduce the probability that key variables can be appropri-
ately structured and included in theoretic models of the
future. Providing appropriate, factual, and relevant infor-
mation to NEP clients appears to be an implied goal of
most NEPs, although data on relative success in transmit-
ting such data to the IDU population is woefully inade-
quate. Only three of the 64 studies examined in detail for
the Ksobiech [14] meta-analysis provided any change/Harm Reduction Journal 2004, 1 http://www.harmreductionjournal.com/content/1/1/4
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comparison data on HIV disease knowledge outcome
measures [15,32,33].
Lack of clearly articulated desirable NEP outcomes
In reviewing the outcome measures of NEP researchers, it
was not always clear whether a given result related to NEP
attendance was desirable or not. Consider, for example,
the dependent variable, "uses bleach," presumably as a
means of cleaning needles and/or syringes. If bleach use
by NEP participants declines over time, is that a negative
or positive outcome?
One reasonable interpretation for a decline in "using
bleach" is that NEP attenders are more likely to use sterile
needles, lessening their need for bleach. If that is one's
view, then a decline in "using bleach" is, in fact, a positive
outcome. On the other hand, if one interprets "using
bleach" as part and parcel of desirable IDU behaviors, its
decline in NEP clients (or less frequent use, when com-
pared to non-NEP clients) would necessarily be inter-
preted as a negative effect.
This ambiguity in NEP outcomes is especially prevalent in
studies measuring changes in drug paraphernalia sharing
behaviors. Beyond "using bleach," other examples
include "boiling water" and "always cleaning the needle
before use." Again, it could certainly be argued that a
decline in such behaviors is related to use of sterile nee-
dles, rather than reusing one's own or others' needles in a
risky manner.
In summary, although there are obvious differences in the
resources available to a given NEP, there will also be cor-
responding differences in their behavioral goals over time.
There is a definite need for the NEP community to articu-
late common goals in clear, concise terms, so that data
being collected evaluate progress toward these goals, and
can be compared, not only within the United States, but
also internationally.
Suggestions for future research
Coordination of research studies
NEPs vary considerably in size and scope, not to mention
community acceptance and legality. Nearly all the
research discussed here was limited to one or several NEPs
in a specific geographic region. Further, most of the stud-
ies appear to be trying to answer this general research
question: Is a given NEP "successful"? That question leads
to data collection procedures that are primarily focused
on information presumably deemed essential to demon-
strate NEP effectiveness to funding sources and/or govern-
mental units.
To date, there has been little effort to link studies across
cities, states, and beyond in a manner that would maxi-
mize comparability. It would be helpful, for example, if
10 NEPs, located in major urban areas of the United
States, cooperated in implementing a series of multi-site,
longitudinal studies, utilizing the same dependent varia-
bles, measured via the same operational definitions, and
then statistically analyzed individually and cumulatively.
Replication of studies
NEP research has thus far not been geared toward replicat-
ing prior studies or utilizing the measurement instru-
ments of others. While the NEP studies analyzed do
attempt to measure similar outcomes, the bulk of the
studies appear to be designed in isolation from each other
and, in many cases, almost appear to be purposefully dif-
ferent from one another. There is an overall need for rep-
lication of NEP studies by location, particularly those that
found uncharacteristically large desirable [34] or undesir-
able [22] effects.
At present, it's not possible to say with certainty that some
studies' results are "outliers" due to poor methodology, an
aberrant sample, or if, in fact, NEP attenders in that partic-
ular location behave differently than NEP participants
elsewhere in the world. These questions, and others, point
to the need for rigorous replication of previously pub-
lished studies.
Use/effectiveness of IDU-related 
communication messages
Scant reference, if any, was made to additional literature
provided to NEP attendees at exchange sites. Presumably,
the intent of such literature would be knowledge-ori-
ented. The impact of such literature on NEP attenders is
another apparently unexplored area. Are print materials
provided being read, or are they merely discarded? How
could such materials be designed for enhanced readability
and/or impact? Research related to message design of sup-
plemental NEP materials is indicated.
Beyond what is handed out at NEP sites, there are signifi-
cant questions about the design and effectiveness of
broadcast public service announcements (PSAs) in the
areas of knowledge and behavior. Given injection drug
use is an illegal activity, it is unlikely that there will be
PSAs about safe injection behaviors broadcast in the
mainstream media anytime soon. Radio PSAs may be
more effective in targeting this "hard to reach" audience.
Groundbreaking work needs to be done in this area.
Further, at NEP sites, there may be an opportunity to
incorporate risk-reduction messages through looped,
brief, videotaped programs. Creating meaningful mes-
sages for this target population is an area to explore. Given
that NEP attenders are typically less educated, designingHarm Reduction Journal 2004, 1 http://www.harmreductionjournal.com/content/1/1/4
Page 6 of 7
(page number not for citation purposes)
and implementing an alternative to print materials may
result in greater impact.
Role of NEP workers/volunteers
There is some necessary interaction between NEP client
and NEP staff in virtually all circumstances, regardless of
whether the NEP is fixed vs. roving, or legal vs. illegal,
unless it is a syringe dispenser method of distributing nee-
dles. Given this face-to-face interaction, this could well be,
at the least, a "teachable moment." Assuming that one
goal of NEPs is building and maintaining a trusting rela-
tionship over time between NEP clients and workers/vol-
unteers, to encourage IDU behavioral modification and
ultimately drug treatment, research needs to be done to
examine this potentially critical/key relationship. Often
former drug users themselves, NEP staff already has a
common ground with NEP clients. It is possible that this
relationship can be enhanced via training NEP staff in per-
suasion compliance strategies.
Differences in types of NEPs
Little comparative information was found on the relative
effectiveness of various types of NEPs (i.e., fixed sites,
mobile vans, outreach workers). Many studies examined
NEPs that provide needles at both fixed and roving sites,
but the results were usually combined. It's possible, as
suggested by Guydish et al. [35], that roving NEP attracts
a different IDU population than fixed sites. Data need to
be gathered to explore that possibility. Such an effort
might lead to employing different communication, edu-
cation, and long-term treatment strategies for fixed-site
clients vs. those frequenting mobile/roving units.
Conclusions
(1) We should be interested in improving_NEPs, not
merely justifying any given NEP's existence by reporting
on basics such as needles distributed/returned. Better-
stated NEP goals, as previously discussed, will assist in
moving NEP outcome evaluations toward this direction.
(2) We need to improve coordination and communica-
tion within the NEP research community. Indeed, it
would appear as though researchers go out of our way to
be certain that a given study's data is not similar to anyone
else's, making comparisons across studies difficult at best.
(3) We need to broaden our perspective on NEP evalua-
tive research. More research is needed in areas such as
risky sexual behaviors and even the most fundamental of
all: HIV/AIDS knowledge.
(4) We need a category system/typology, within which
discernibly different dependent variables are considered
to be equivalent.
(5) For all the studies, all the effort, all the publications,
we know surprisingly little about relationships between
and among the multitude of variables related to HIV/
AIDS prevention. As we talk with one another, use the
same DVs, defined the same way, and measure them with
valid/reliable instruments, that scenario should improve.
Until then, we'll just be "going through the motions," pre-
tending that we're moving forward in this critical area.
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